Merit Medical Systems Inc
4 nominees · 5 ballot items.
Election of four directors; advisory approval of executive compensation (Say-on-Pay); approval of the 2026 Equity Incentive Plan; approval of the 2026 Employee Stock Purchase Plan; and ratification of Deloitte & Touche LLP as independent auditors.
Follow how the vote landed and what changed on Merit Medical Systems Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot5
- 1
Election of Four Nominees for Director
ManagementBoard: FORElect four directors: Martha G. Aronson, Lonny J. Carpenter, Lynne N. Ward, and Scott R. Ward; three nominees to serve three-year terms and Lynne N. Ward to serve a one-year term.
- 2
Advisory Vote on Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding, advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
- 3
Approval of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan
ManagementBoard: FORApprove the 2026 Equity Incentive Plan, authorizing issuance of up to 2,700,000 shares to support equity grants for employees, directors, and consultants.
- 4
Approval of the Merit Medical Systems, Inc. 2026 Employee Stock Purchase Plan
ManagementBoard: FORApprove the 2026 Employee Stock Purchase Plan to allow employees to purchase shares through payroll deductions, authorizing 500,000 shares.
- 5
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Nominees on the ballot4
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.5% | 6,244,155 | $430M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.9% | 3,523,088 | $243M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 2,656,163 | $183M |
| 4 | STATE STREET CORP | 4.0% | 2,360,982 | $163M |
| 5 | Conestoga Capital Advisors, LLC | 3.6% | 2,167,513 | $149M |
| 6 | FULLER THALER ASSET MANAGEMENT, INC. | 3.5% | 2,115,526 | $146M |
| 7 | BlackRock, Inc. | 2.9% | 1,726,308 | $119M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,300,214 | $90M |
| 9 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.0% | 1,198,269 | $83M |
| 10 | Greenhouse Funds LLLP | 1.9% | 1,122,447 | $77M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Merit Medical Systems Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Merit Medical Systems Inc 2026 annual meeting?
- Merit Medical Systems Inc (MMSI) holds its 2026 annual shareholder meeting on Wednesday, May 13, 2026.
- What is the record date for the Merit Medical Systems Inc 2026 meeting?
- The record date for the Merit Medical Systems Inc 2026 meeting is Friday, March 20, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Merit Medical Systems Inc's 2026 meeting?
- The board is presenting 4 director nominees at the Merit Medical Systems Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Merit Medical Systems Inc 2026 meeting?
- Shareholders will vote on 5 proposals at the Merit Medical Systems Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.